Drug recall · September 4, 2013
Benztropine Mesylate Injection recall
Why: Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nexus Pharmaceuticals Inc, Lincolnshire, IL 60069, NDC 14789-300-02
- Lots / codes
a) Lot: 112911, Exp. 11/13, b) Lot: 030712, Exp. 3/14
- Quantity
- 46,185 vials
- Company
- Nexus Pharmaceuticals Inc, Vernon Hills, IL
- Distribution
- Nationwide
- Initiated
- August 1, 2013 · Voluntary: Firm initiated
- Classified
- August 27, 2013
- Reported
- September 4, 2013
- Ended
- February 8, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Benztropine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.